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Background
Tuberculosis (TB), one of the oldest infectious diseases
known to mankind, is a major cause of death for human
immunodeficiency virus (HIV) infected people. Since
2008, the HIV/AIDS Mureş Regional Centre has been
monitoring the increase in cases of HIV-TB with drug-
resistant mycobacteria (MTB). We have decided to analyze
particular aspects of this phenomenon.
Methods
Retrospective cross-sectional study performed in the Infec-
tious Diseases Clinic I Tîrgu Mureş during the period of
2008-2012. The study included HIV positive patients diag-
nosed with drug-resistant tuberculosis (TB-R). We moni-
tored epidemiological and clinical data as well as the
evolution of the disease. We compared the results with
those of patients diagnosed during the period of 2003-
2012 with HIV-drug-sensitive TB (TB-nR). For statistical
analysis we used the Fisher and T tests.
Results
83 patients were diagnosed with HIV-TB-nR with an aver-
age age of 23 years. 36 were without antiretroviral therapy
(ART), with a CD4 count of 198 cells/µL; 73% were adher-
ent to ART, 32% have deceased. 25 patients were
diagnosed with HIV-TB-R (with an average age 25.6 years,
over 50% were male) 7 of which were MDR, 11 pre-XDR,
7 XDR. Most cases of HIV TB-R were recorded in 2011,
(8 cases of which 2 MDR, 6 pre-XDR). The patients
suffered predominantly from secondary pulmonary TB
(22) but also from extra pulmonary TB like meningoence-
phalitis (8). Resistance to isoniazid and rifampin was 100%
(MDR), resistance to ethambutol 66.97%, 62.96% to
streptomycin, 33.33% to kanamycin, 55.56% to quinolones.
All strains maintained their sensitivity towards ethiona-
mide, cycloserine, para-aminosalicylic acid. Hospitalization
periods for patients with MDR were significantly longer
(68 days) than those of patients without MDR (44 days):
T test p=0.0045. The adherence to ART of TB-R patients
was much lower than that of TB-nR patients (odds ratio
2.12, Fisher test p=0.04). We have not found significant
statistical difference between CD4 lymphocyte numbers
in MDR (140 cells/µL) and non-MDR patients. Drug-
resistance has had significant statistical influence over the
mortality rate of patients (odds ratio, 3.11, Fisher test
p=0.019).
Conclusion
The incidence of HIV-TB-R is increasing with long hospi-
talization periods, difficult therapy, low adherence and
high mortality rate.
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